Abstract | BACKGROUND: METHODS AND RESULTS: The incidence and clinical characteristics of AIT were examined retrospectively in 71 patients (51 males, mean age 65±13 years) whose amiodarone therapy had been discontinued after at least 1 month of administration. Five (7%) patients developed AIT late after amiodarone withdrawal (11±3 months): 2 patients exhibited exacerbation of heart failure by atrial fibrillation, 2 developed dyspnea on exertion, and 1 patient was asymptomatic. The patients who developed AIT had a high incidence of amiodarone-induced hypothyroidism during amiodarone therapy (100 vs. 24%, P=0.002), had received amiodarone therapy for longer (76±86 months vs. 16±22 months, P<0.001), with a larger cumulative dose (271.1±268.5 g vs. 63.4±86.5 g, P<0.001) compared with those who did not. In all 5 patients, AIT resolved spontaneously within 5 months without the use of steroids. CONCLUSIONS:
|
Authors | Atsuhiko Yagishita, Hitoshi Hachiya, Mihoko Kawabata, Tomofumi Nakamura, Koji Sugiyama, Yasuaki Tanaka, Tetsuo Sasano, Mitsuaki Isobe, Kenzo Hirao |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 77
Issue 12
Pg. 2898-903
( 2013)
ISSN: 1347-4820 [Electronic] Japan |
PMID | 24042320
(Publication Type: Clinical Trial, Journal Article, Multicenter Study)
|
Chemical References |
- Anti-Arrhythmia Agents
- Amiodarone
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Amiodarone
(administration & dosage, adverse effects)
- Anti-Arrhythmia Agents
(administration & dosage, adverse effects)
- Atrial Fibrillation
(chemically induced, epidemiology)
- Dyspnea
(chemically induced, epidemiology)
- Female
- Humans
- Male
- Middle Aged
- Retrospective Studies
- Thyrotoxicosis
(chemically induced, epidemiology)
- Time Factors
|